Log in to our secure, personalized website to manage your care (formerly myMDAnderson).
If you are ready to make an appointment, select a button on the right.
If you have questions about MD Anderson’s appointment process, our
information page may be the best place to start.
Find information and resources for current and returning patients.
Learn about clinical trials at MD Anderson and search our database for open studies.
The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.
Your gift will help support our mission to end cancer and make a difference in the lives of our patients.
Our personalized portal helps you refer your patients and communicate with their MD Anderson care team.
As part of our mission to eliminate cancer, MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.
Choose from 12 allied health programs at School of Health Professions.
Learn about our graduate medical education residency and fellowship opportunities.
The B-Cell Lymphoma Moon Shot is revolutionizing the conventional medical research approach to rapidly translate findings into patient treatment options and develop personalized therapeutic strategies.
For 75 years, MD Anderson has changed the world by bringing life-saving
innovation from research labs into the homes and hearts of millions.
Learn how our history is shaping your future.
You might be surprised to know our namesake wasn't a physician, but a humble banker from Tennessee.
Meet MD Anderson's fifth full-time president.
The Council monitors, reviews, advises & provides recommendations about high level efforts that impact the institution.
These distinguished leaders steered MD Anderson through more than seven decades of cancer care.
MD Anderson makes available a cache of agency reports in electronic form.
MD Anderson Cancer Center has been consistently accredited by The Joint Commission since 1951.
MD Anderson is ranked #1 in cancer care by U.S. News and World
MD Anderson has launched an ambitious plan to accelerate the end cancer.